NBC News Producer Personal Journey – It’s all About Early Detection & Prevention - Hawaii First Alzheimer’s Prevention Trial - PrevenTRON now Accepting Patients
PrevenTRON, Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk for Alzheimer using Novel Trontinemab Engineered with Brainshuttle™ Technology with Rapid Amyloid Clearance and Low ARIA
NBC News Reports New treatments to fight off Alzheimer’sWatch on YouTube
NBC Senior Producer Sue Kroll travels the world covering the news, but tonight she shares her own story about her battle to fend off Alzheimer’s and the steps she’s taking to avoid the brutal disease.
Hawaii is part of a national program to offer its first ever Alzheimer’s Prevention Trial – PrevenTRON is a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk for Alzheimer using Novel Trontinemab Engineered with Brainshuttle™ Technology with Rapid Amyloid Clearance and Low ARIA in a randomized, multicenter, double-blind, placebo-controlled study targeting approximately 1,600 cognitively unimpaired participants at high risk of progression to symptomatic AD.
Who Qualifies?
- 55-80 years old, MMSE >25
- Family history of Alzheimer’s OR Positive for either PTau217 or ApoE4
“Hawaii patients & their ohana, our neurologists & researchers are honored to be selected to be the Hawaii site for this important milestone Prevention Study in the steps to fight against Alzheimer’s diseases and to improve the lives of those living with them.”
Michael Sonson, MDNeurologist, Director & Investigator, Hawaii Memory Disorders Ctr & Alz Research Unit
